I-Mab
ANTI-LAG-3 ANTIBODIES AND USES THEREOF
Last updated:
Abstract:
The present disclosure provides antibodies that bind Lymphocyte Activation Gene-3 (LAG-3). Also provided are methods of stimulating an immune response, inhibiting growth of tumor cells, and treating an autoimmune, inflammatory, or viral disease.
Status:
Application
Type:
Utility
Filling date:
18 Nov 2019
Issue date:
5 Mar 2020